Provided by Tiger Trade Technology Pte. Ltd.

Caribou Biosciences

1.66
+0.05003.11%
Post-market: 1.680.0191+1.15%19:30 EDT
Volume:1.16M
Turnover:1.93M
Market Cap:177.62M
PE:-1.54
High:1.69
Open:1.64
Low:1.62
Close:1.61
52wk High:3.54
52wk Low:1.38
Shares:107.00M
Float Shares:102.16M
Volume Ratio:1.13
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0751
EPS(LYR):-1.5900
ROE:-78.27%
ROA:-36.84%
PB:1.81
PE(LYR):-1.04

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE -Shake Shack, Perpetua, Caribou Biosciences

Reuters
·
Apr 01

Caribou Biosciences Gains RMAT Status for CB-011 Therapy

TIPRANKS
·
Mar 31

BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy

Reuters
·
Mar 31

Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (Rmat) Designation to CB-011, an Allogeneic Anti-Bcma CAR-T Cell Therapy

THOMSON REUTERS
·
Mar 31

Caribou Biosciences Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Mar 10

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Ardent Health Partners, Inc. (ARDT) and Caribou Biosciences (CRBU)

TIPRANKS
·
Mar 09

Caribou Biosciences: Advancing Allogeneic Cell Therapy Pipeline and Pivotal Trial Plans Support High-Risk Buy Rating

TIPRANKS
·
Mar 07

Drug Pricing Reforms Threaten Caribou Biosciences’ Future Margins and Market Access

TIPRANKS
·
Mar 07

Leerink Partners Remains a Buy on Caribou Biosciences (CRBU)

TIPRANKS
·
Mar 06

Clear Street Sticks to Their Buy Rating for Caribou Biosciences (CRBU)

TIPRANKS
·
Mar 06

Caribou Biosciences Q4 licensing revenue rises, net loss narrows

Reuters
·
Mar 06

Caribou Biosciences Q4 EPS $(0.28) Beats $(0.33) Estimate, Sales $3.941M Beat $2.610M Estimate

Benzinga Earnings
·
Mar 06

Caribou Bio FY 2025 licensing and collaboration revenue rises 11.2% to USD 11.2 million

Reuters
·
Mar 06

BRIEF-Caribou Biosciences Q4 Licensing And Collaboration Revenue USD 3.941 Million

Reuters
·
Mar 06

Caribou Biosciences Q4 Basic EPS USD -0.28

THOMSON REUTERS
·
Mar 06

Press Release: Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 06

Insider Shake-Up: Top Caribou Biosciences Executive Trims Stake in the Company

TIPRANKS
·
Feb 28

Caribou Biosciences Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Feb 28

Caribou Biosciences CTO Timothy P Kelly Disposes of Common Shares

Reuters
·
Feb 28

Caribou Biosciences (CRBU) Receives a Buy from Citi

TIPRANKS
·
Feb 20